Maternal death is a tragedy in any setting. Unfortunately, the US has maternal mortality far higher than many other wellresourced nations. 1 Moreover, egregious disparities within the US population persist: Alaska Native, American Indian, and Black individuals experience maternal mortality rates 2 to 3 times those of White individuals, and rates among Hispanic individuals are at an alltime high. 2,3 The fact that approximately 80% of maternal deaths are preventable 4 highlights the urgency and responsibility for all clinicians to ensure that pregnant-capable, pregnant, and postpartum individuals are screened, counseled, and treated for one of the leading contributors to maternal deaths: hypertensive disorders of pregnancy (HDP). In this context, the US Preventive Services Task Force (USPSTF) should be applauded for its updated recommendation statement and expansion of focus to the 2017 recommendation for screening for preeclampsia among pregnant persons. 5,6 Given the US's abysmal track record in addressing maternal mortality, a new sense of "hypertensive urgency" is required: screening for and addressing HDP must be prioritized and addressed with a renewed focus by clinicians, policymakers, and the research community.The USPSTF maintained its B recommendation, 5 which was supported by an updated evidence report and systematic review, 7 with an expanded scope to screen for all HDP, including gestational hypertension, preeclampsia, eclampsia, and chronic hypertension with superimposed preeclampsia or eclampsia. This extension of the screening scope beyond a sole focus on preeclampsia is timely and appropriate, as all HDP rates have increased since 1990 4 and comprise a substantial contributor to maternal mortality and morbidity. 4 It is important to note that pregnancy is not the only time when screening, counseling, and treatment should occur. All persons who have reproductive capacity and/or are planning pregnancy, along with those who are post partum, should be screened for hypertensive disorders, aligning the USPSTF with guidelines from the American College of Obstetricians and Gynecologists, the American College of Cardiology, and the American Heart Association. 8 Opinion EDITORIAL